Evidence for the effectiveness of anti-hypertensive medicines included on the Chinese National Reimbursement Drug List

Evidence for the effectiveness of anti-hypertensive medicines included on the Chinese National Reimbursement Drug List

Abstract Background Evidence-based decision on drug list or formulary has been applied worldwide. Although the importance of scientific evidence was emphasized, the decision-making procedures for including medicines into the national reimbursement drug list were often challenged by their process opa...

Full description

Bibliographic Details
Main Authors: Wenbin Liu, Lizheng Shi, Monika Sawhney, Xiaoli Gu, Yingyao Chen
Format: Article
Language:English
Published: BMC 2019-02-01
Series:BMC Health Services Research
Subjects:
Evidence support
National Reimbursement Drug List (NRDL)
Antihypertensive medicines
Urban employee basic medical insurance (UEBMI)
China
Online Access:http://link.springer.com/article/10.1186/s12913-019-3937-0

Internet

http://link.springer.com/article/10.1186/s12913-019-3937-0

Similar Items